Cogent Diagnotics , Ltd.

Cogent Diagnotics , Ltd. — FDA 510(k) Submissions

Cogent Diagnotics , Ltd. has submitted 31 FDA 510(k) premarket notifications since 1992, of which 31 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include Extractable Antinuclear Antibody, Antigen And Control, System, Test, Anticardiolipin Immunological, Immunochemical, Thyroglobulin Autoantibody, System, Test, Rheumatoid Factor, Test System, Antineutrophil Cytoplasmic Antibodies (anca) . Use the specialty filter in the sidebar to narrow results.